Company intelligence / Profile preview

Normalyte

Sellersburg, Indiana, United States
Ownership
Private
Development stage
Other
01

Overview

NormaLyte is a healthcare company specializing in medical-grade oral rehydration salts (ORS) designed specifically for patients with chronic conditions such as Postural Orthostatic Tachycardia Syndrome (POTS), Dysautonomia, and Ehlers-Danlos Syndrome (EDS). The company's products are formulated based on the World Health Organization's (WHO) standards for oral rehydration therapy, providing an efficient method for rapid electrolyte replenishment and volume expansion. NormaLyte distinguishes itself by offering specialized versions of its products, including a PURE line that is free from artificial sweeteners, flavors, and dyes to accommodate patients with high sensitivities. The company serves a niche but significant patient population that requires high-sodium intake to manage symptoms of orthostatic intolerance and chronic dehydration.

Therapeutic areas
CardiovascularNeurologyRare DiseasesMetabolic Disorders
Modalities
Oral rehydration saltsElectrolytes
Industry
Food & Nutrition
02

Partnerships

Dysautonomia International

Beyond the preview

Go deeper on Normalyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Normalyte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call